Where does Tecnimede—Sociedade Técnico-Medicinal, SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tecnimede—Sociedade Técnico-Medicinal, SA ranks #30,344 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tecnimede—Sociedade Técnico-Medicinal, SA hold?

Tecnimede—Sociedade Técnico-Medicinal, SA holds 9 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Tecnimede—Sociedade Técnico-Medicinal, SA's Innovation Score?

Tecnimede—Sociedade Técnico-Medicinal, SA has an Innovation Score of 26.3 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tecnimede—Sociedade Técnico-Medicinal, SA focus on?

Tecnimede—Sociedade Técnico-Medicinal, SA's top technology area is C07D (Heterocyclic Compounds) with 7 patents. Grants appear in 4 CPC subclasses total.

Is Tecnimede—Sociedade Técnico-Medicinal, SA's patent grant rate increasing or decreasing?

Tecnimede—Sociedade Técnico-Medicinal, SA's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Tecnimede—Sociedade Técnico-Medicinal, SA's patents?

Tecnimede—Sociedade Técnico-Medicinal, SA's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Tecnimede—Sociedade Técnico-Medicinal, SA

Q: How is the Tecnimede—Sociedade Técnico-Medicinal, SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tecnimede—sociedade ranks #30,344 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 4 technology areas.

#30,344
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.3/100): 18.8
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30344 · Foreign Corporation #30,344 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #30,344/49,997
PHOTO-FINISH Teal Drones
CPC-NARROW C07D · 4 areas
INNOV-THIN 26.3/100
CLAIMS-RICH 18.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Teal Drones, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Tecnimede—Sociedade… · this assignee

26
3D Lighting… · lowest

7

What this shows Tecnimede—sociedade's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Tecnimede—sociedade's grants concentrate

Tecnimede—Sociedade Técnico-Medicinal, SA is a focused PatentsView assignee: 4 CPC subclasses with 77.8% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2019. By volume, Tecnimede—sociedade sits between Teal Drones, Inc. and Telephonics Corp..

Teal Drones

9
Tearoptix

9
Tecmed

9
Technip E&C

9
Tedder Industries

9
Teewinot

9
Teledrill

9
Telephonics

9
Tecnimede—Socieda… ◀

9

What this shows Tecnimede—Sociedade holds 9 patents at rank #30,372, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tecnimede—Sociedade

By rank, the assignees closest to #30,372 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Tecnimede—Sociedade's primary technology class.

Tecnimede—sociedade's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Tecnimede—Sociedade Técnico-Medicinal, SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	4	44.4%
2019	1	11.1%
2020	1	11.1%
2021	2	22.2%
2025partial year	1	11.1%

Which technologies does Tecnimede—Sociedade Técnico-Medicinal, SA patent most?

C07D - Heterocyclic Compounds 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#30,344

of 49,997 tracked assignees

Innovation Score

26.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Tecnimede—Sociedade Técnico-Medicinal, SA's patent record in context - here's where to go next.

Tecnimede—Sociedade Técnico-Medicinal, SA's lead technology class is C07D (Heterocyclic Compounds), 77.8% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #30,344 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tecnimede—Sociedade Técnico-Medicinal, SA against Teal Drones, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.